Excellent — I have strong guideline-based content. Let me now compile the full, comprehensive answer for MD exams.
Non-Tuberculous Mycobacteria (NTM) — Diagnosis: Full MD Exam Guide
1. Introduction & Classification
Non-tuberculous mycobacteria (NTM) are mycobacterial species other than M. tuberculosis complex and M. leprae. Also called:
- Atypical mycobacteria
- Environmental mycobacteria
- MOTT (Mycobacteria Other Than Tuberculosis)
Runyon Classification (Classic Exam Table)
| Group | Name | Growth | Pigment | Key Species |
|---|
| I | Photochromogens | Slow | In light | M. kansasii, M. marinum |
| II | Scotochromogens | Slow | In dark | M. scrofulaceum, M. gordonae |
| III | Nonchromogens | Slow | None | M. avium complex (MAC), M. ulcerans, M. xenopi |
| IV | Rapid growers | Fast (<7 days) | Variable | M. fortuitum, M. chelonae, M. abscessus |
Exam tip: MAC (Group III) is the most common NTM causing pulmonary disease in immunocompetent adults.
2. Epidemiology & Risk Factors
Host Risk Factors
Pulmonary NTM:
- Structural lung disease: bronchiectasis, COPD, prior TB, pneumoconiosis, CF
- Lady Windermere syndrome: slender, elderly women with scoliosis/pectus excavatum
- Immunosuppression (HIV/AIDS — CD4 <50 for disseminated MAC)
- Use of inhaled corticosteroids
Disseminated NTM:
- HIV with CD4 <50 cells/µL (MAC most common)
- Primary immunodeficiencies (IFN-γ/IL-12 pathway defects)
- Anti-IFN-γ autoantibodies (Southeast Asian patients)
3. Clinical Presentations
A. Pulmonary Disease (Most Common Form)
Two main radiologic patterns:
| Feature | Fibrocavitary Form | Nodular Bronchiectatic Form |
|---|
| Demographics | Older males, smokers | Older women (Lady Windermere) |
| Chest X-ray | Apical cavities | Middle lobe/lingular nodules |
| HRCT | Thick-walled cavities | Tree-in-bud, bronchiectasis, nodules |
| Species | M. kansasii, MAC | MAC |
| Course | More aggressive | Indolent |
Symptoms: Chronic cough, hemoptysis, fatigue, weight loss, night sweats — indistinguishable from pulmonary TB
B. Lymphadenitis
- Most common NTM disease in children
- Cervical > submandibular nodes (unilateral, non-tender)
- Species: MAC > M. scrofulaceum > M. kansasii
- Violaceous skin, may spontaneously drain (scrofula-like, but NTM in immunocompetent child)
- Exam key: NTM lymphadenitis in a child — not MTB; treat with surgical excision
C. Skin and Soft Tissue / Bone
- Buruli ulcer: M. ulcerans — painless necrotic ulcer, Africa; toxin mycolactone
- Fish tank granuloma: M. marinum — nodular lesion on hand/elbow after aquarium exposure
- Rapidly growing mycobacteria (RGM): M. abscessus, M. fortuitum — post-surgical/injection abscesses
D. Disseminated MAC (HIV)
- CD4 <50 cells/µL
- Fever, night sweats, weight loss, hepatosplenomegaly
- Very high LDH and alkaline phosphatase
- Pancytopenia (bone marrow infiltration)
- Diagnosis: blood culture (lysis-centrifugation) or bone marrow biopsy
4. Diagnosis — The Core Exam Topic
ATS/IDSA Diagnostic Criteria for NTM Pulmonary Disease (2020 Guidelines)
Treatment of Nontuberculous Mycobacterial Pulmonary Disease, ATS/ERS/ESCMID/IDSA, p. 2
Both clinical AND microbiologic criteria must be met:
✅ CLINICAL Criteria (BOTH required):
- Pulmonary symptoms (cough, hemoptysis, dyspnea) AND
- Radiographic findings: nodular or cavitary opacities on CXR, OR HRCT showing multifocal bronchiectasis with multiple small nodules
- Appropriate exclusion of other diagnoses (TB, fungi, malignancy)
✅ MICROBIOLOGIC Criteria (ONE of the following):
| Option | Requirement |
|---|
| Sputum cultures | ≥2 positive sputum cultures for the same NTM species |
| Bronchoscopy | ≥1 positive bronchial wash/lavage culture |
| Biopsy | Transbronchial/lung biopsy with granulomatous inflammation or AFB + ≥1 positive NTM culture from sputum/lavage |
Critical exam point (ATS 2020, p. 2): A single positive sputum culture is NOT diagnostic — clinically significant MAC pulmonary disease is unlikely with 1 positive culture but up to 98% likely with ≥2 positive cultures of the same species.
Diagnostic Workup — Step by Step
Step 1: Clinical suspicion
↓
Step 2: Chest X-ray + HRCT chest
↓
Step 3: Sputum × 3 (AFB smear + Mycobacterial culture)
↓ (if sputum non-diagnostic)
Step 4: Bronchoscopy → BAL / bronchial wash for AFB culture
↓ (if still needed)
Step 5: CT-guided lung biopsy / transbronchial biopsy
↓
Step 6: Species identification (nucleic acid probes, HPLC, 16S rRNA gene sequencing)
↓
Step 7: Drug susceptibility testing (DST)
Key Laboratory Investigations
| Test | Details |
|---|
| AFB smear | Rapid but low sensitivity; cannot distinguish NTM from MTB |
| Mycobacterial culture | Gold standard; Lowenstein-Jensen (L-J) or MGIT liquid media; 2–6 weeks for slow growers, <7 days for rapid growers |
| Species identification | DNA probes (AccuProbe), 16S rRNA sequencing, MALDI-TOF, HPLC |
| Drug Susceptibility Testing (DST) | Essential for treatment planning |
| HRCT chest | Bronchiectasis + tree-in-bud nodules (nodular-bronchiectatic); cavities (fibrocavitary) |
| CBC, LFT, ALP | Elevated ALP/LDH → disseminated MAC |
| HIV test | Mandatory in disseminated NTM |
| Blood culture | Lysis-centrifugation for disseminated MAC (HIV) |
| Bone marrow biopsy | Disseminated MAC — granulomas with AFB |
| Interferon-gamma Release Assay (IGRA) | NEGATIVE in NTM (does not cross-react with MAC/NTM); positive only for MTB ✓ |
| Tuberculin Skin Test (TST/Mantoux) | May be weakly positive (cross-reactivity with M. kansasii, M. marinum) but weaker than MTB |
Exam trap: IGRA (QuantiFERON-TB Gold) is negative in NTM — this helps differentiate NTM from MTB. TST can show weak positivity with some NTM species.
HRCT Findings — High-Yield
| Pattern | Description | Associated Form |
|---|
| Tree-in-bud nodules | Centrilobular nodules with branching | Nodular-bronchiectatic |
| Cylindrical bronchiectasis | Middle lobe & lingula predominantly | Nodular-bronchiectatic (Lady Windermere) |
| Cavitation | Thin or thick-walled apical cavities | Fibrocavitary |
| Consolidation | Segmental/lobar | Hypersensitivity-like (hot tub lung) |
| Ground glass opacities | Diffuse in hypersensitivity pneumonitis variant | Hot tub lung (M. avium) |
5. Specific NTM Species — Diagnosis Pearls
| Species | Key Clinical Pearl | Diagnosis Clue |
|---|
| MAC (M. avium-intracellulare) | Most common NTM; pulmonary + disseminated in AIDS | ≥2 sputum cultures; blood culture in HIV |
| M. kansasii | Resembles TB clinically and radiologically; apical cavities | Positive AccuProbe; responds to rifampicin |
| M. abscessus | Most drug-resistant NTM; CF patients | RGM <7 days; macrolide susceptibility testing critical |
| M. fortuitum | Post-surgical/injection abscesses | RGM; skin/soft tissue |
| M. marinum | Aquarium/fish tank exposure; fish tank granuloma | History + skin biopsy + culture at 30°C (not 37°C!) |
| M. ulcerans | Buruli ulcer; painless necrotic ulcer | PCR + culture; Africa/Australia |
| M. scrofulaceum | Cervical lymphadenitis in children | Surgical excision diagnostic + curative |
| M. xenopi | Pulmonary; immunocompromised; UK common | Slow grower at 42°C |
| M. haemophilum | Skin/joint in immunocompromised | Requires iron-supplemented media + 30°C |
Exam tip for M. marinum: Culture must be done at 30°C, not 37°C — it will not grow at body temperature.
Exam tip for M. haemophilum: Requires hemin-supplemented media — lab must be alerted.
6. Differentiating NTM from MTB — Exam Table
| Feature | NTM | MTB |
|---|
| Transmission | Environmental (soil, water) — NOT person-to-person | Person-to-person (droplet) |
| Contagious | No | Yes |
| Contact tracing | Not required | Required |
| Isolation | Not required | Required |
| IGRA / QuantiFERON | Negative | Positive |
| TST | Weak/negative (except M. kansasii) | Strongly positive |
| Culture time | Weeks (varies by species) | 3–6 weeks |
| Drug sensitivity | Resistant to many anti-TB drugs | Standard RHEZ regimen |
| Niacin test | Negative | Positive (MTB) |
| Nitrate reduction | Varies | Positive (MTB) |
| Growth on PNB (p-nitrobenzoic acid) | Grows (NTM) | Inhibited (MTB) |
7. Special Scenarios
Hot Tub Lung (M. avium)
- Hypersensitivity pneumonitis from MAC aerosolized in hot tubs
- Dyspnea, cough, fever after hot tub exposure
- HRCT: diffuse ground glass + nodules
- Diagnosis: BAL + culture + clinical history
- Treatment: Avoidance (± steroids) — antituberculars not always needed
Lady Windermere Syndrome
- Elderly, slender women; right middle lobe/lingula bronchiectasis
- MAC most common
- Chronic productive cough; no underlying lung disease
- Caused by deliberate cough suppression → impaired mucociliary clearance
NTM in Cystic Fibrosis (ATS/IDSA Guidelines, p. 8)
- M. abscessus most important — can prevent lung transplantation
- Screening with annual sputum AFB cultures recommended
- Diagnosis: same ATS/IDSA criteria apply
- Treatment challenging — multidrug regimens, surgical debridement
Disseminated MAC in HIV
- CD4 <50 → start MAC prophylaxis (azithromycin weekly)
- Diagnosis: blood cultures (lysis-centrifugation) — most sensitive
- Features: fever, wasting, hepatosplenomegaly, markedly elevated ALP
8. Key Exam Points — Quick Recall
| # | High-Yield Point |
|---|
| 1 | ≥2 positive sputum cultures required for NTM-PD diagnosis (same species) |
| 2 | Single positive sputum = NOT diagnostic |
| 3 | IGRA negative in NTM (key differentiator from TB) |
| 4 | NTM is NOT transmitted person-to-person — no isolation/contact tracing |
| 5 | M. marinum culture at 30°C; M. haemophilum needs hemin media |
| 6 | Niacin test positive → MTB; NTM = negative |
| 7 | PNB (p-nitrobenzoic acid): NTM grows; MTB is inhibited |
| 8 | Disseminated MAC in HIV: CD4 <50; diagnose with blood cultures |
| 9 | M. abscessus = most drug-resistant NTM; common in CF |
| 10 | Lady Windermere = elderly woman + MAC + RML/lingula bronchiectasis |
| 11 | Children with cervical lymphadenitis → NTM (MAC/M. scrofulaceum); treat with excision |
| 12 | Buruli ulcer = M. ulcerans; Fish tank granuloma = M. marinum |
| 13 | Making a diagnosis of NTM-PD does NOT automatically mandate treatment — individualize |
9. Summary Diagnostic Algorithm
Suspected NTM disease
│
┌────▼────┐
│ Clinical │ Symptoms + CXR/HRCT (nodules, bronchiectasis, cavities)
└────┬────┘
│
┌────▼────────────┐
│ Sputum AFB ×3 │ Culture on Lowenstein-Jensen / MGIT
└────┬────────────┘
│
┌─────▼──────┐
│ ≥2 positive │ → Identify species (AccuProbe / 16S rRNA)
│ same species│ → DST → Diagnose NTM-PD ✓
└─────┬───────┘
│ If non-diagnostic
┌────▼──────────────┐
│ Bronchoscopy BAL │ ≥1 positive culture → Diagnose NTM-PD ✓
└────┬──────────────┘
│ Still inconclusive
┌────▼──────────────┐
│ Lung biopsy │ Granulomas/AFB + ≥1 culture → Diagnose ✓
└───────────────────┘
Sources: ATS/ERS/ESCMID/IDSA Treatment of Nontuberculous Mycobacterial Pulmonary Disease (2020), p. 2; Management of NTM in Individuals with Cystic Fibrosis (ATS/IDSA), p. 8; supplemented with Harrison's Principles of Internal Medicine and standard microbiology references.